Management of advanced genitourinary tumors

Research output: Contribution to journalArticlepeer-review


The management of advanced genitourinary tumors is rapidly evolving thanks to the clinical availability of several targeted drugs with different mechanisms of action. Among clinicians, in-depth knowledge of all the aspects of the disease, together with the capacity to interpret and accurately correlate clinical data and imaging findings, are strongly needed. Moreover, the optimization of treatment sequences might lead to better disease control with respect to prognostic categories, radiological monitoring and newer biomarkers. Among the genitourinary tumors, only few data are available on bladder, testicular and penile cancers. Our report is supported by scientific and clinical experience in renal cell carcinoma and prostate cancer.

Original languageEnglish
Pages (from-to)264-266
Number of pages3
Issue number2
Publication statusPublished - Mar 2012


  • Genitourinary tumors
  • Renal cell carcinoma
  • Sorafenib
  • Sunitinib
  • Targeted therapies

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Management of advanced genitourinary tumors'. Together they form a unique fingerprint.

Cite this